Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

INOINOVIO PHARMACEUTICALS, INC.

Nasdaq · CIK 0001055726
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts441

Identity from submissions API

NameINOVIO PHARMACEUTICALS, INC.
CIK0001055726
TickersINO
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC2834 Pharmaceutical Preparations
EIN330969592
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone8584103134
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • INOVIO BIOMEDICAL CORP (2005-04-04T04:00:00.000Z → 2010-05-11T04:00:00.000Z)
  • GENETRONICS BIOMEDICAL CORP (2001-12-04T05:00:00.000Z → 2005-04-01T05:00:00.000Z)
  • GENETRONICS BIOMEDICAL LTD (1999-09-01T04:00:00.000Z → 2001-08-03T04:00:00.000Z)
Business address
660 W. GERMANTOWN PIKE
SUITE 110
PLYMOUTH MEETING
PA
19462
PA
Mailing address
660 W. GERMANTOWN PIKE
SUITE 110
PLYMOUTH MEETING
PA
19462
PA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

1304 filing rows loaded from submissions recent; extra archives: CIK0001055726-submissions-001.json (304 filings, 1999-06-29 to 2008-05-05).

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-17 8-K 8-K 5.02 0001193125-26-465502 001-14888 261566059 34 140977 1 1
2026-11-16 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-128721 005-60487 261563788 34 16257
2026-11-16 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001214659-26-014444 005-60487 261562481 34 31360
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001172661-26-005390 005-60487 261561964 34 10842
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000919574-26-007926 005-60487 261555708 34 11258
2026-11-10 8-K 8-K 2.02,9.01 0001055726-26-000030 001-14888 261540332 34 280654 1 1
2026-11-10 10-Q 10-Q 0001055726-26-000029 001-14888 261540153 34 9378236 1 1
2026-11-09 8-K 8-K 1.01,7.01,8.01,9.01 0001193125-26-452658 001-14888 261533818 34 628399 1 1
2026-11-06 424B5 424B5 0001193125-26-451932 333-297233 261532460 33 637510
2026-11-06 FWP FWP 0001193125-26-450394 333-297233 261529002 34 115209
2026-11-05 8-K 8-K 2.02 0001193125-26-449853 001-14888 261527497 34 141980 1 1
2026-11-05 424B5 424B5 0001193125-26-449837 333-297233 261527418 33 603784
2026-11-05 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000315066-26-002763 005-60487 261526199 34 12238
2026-11-02 8-K 8-K 7.01,8.01,9.01 0001193125-26-442648 001-14888 261509884 34 2745425 1 1
2026-10-06 8-K 8-K 5.03,9.01 0001193125-26-415555 001-14888 261444069 34 151981 1 1
2026-08-12 8-K 8-K 2.02,9.01 0001055726-26-000024 001-14888 261267506 34 271356 1 1
2026-08-12 10-Q 10-Q 0001055726-26-000023 001-14888 261267300 34 9157890 1 1
2026-08-12 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000919574-26-004959 005-60487 261266214 34 13503
2026-08-07 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001346824-26-000216 005-60487 261254150 34 20189
2026-08-06 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000315066-26-002045 005-60487 261247092 34 12018
2026-07-31 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0002100119-26-001406 005-60487 261226034 34 7793
2026-07-31 8-K 8-K 1.01,8.01,9.01 0001193125-26-326785 001-14888 261225419 34 684129 1 1
2026-07-30 424B5 424B5 0001193125-26-326370 333-297233 261224597 33 743921
2026-07-29 8-K 8-K 2.02 0001193125-26-323628 001-14888 261217318 34 137444 1 1
2026-07-29 424B5 424B5 0001193125-26-323616 333-297233 261217270 33 745283
2026-07-10 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-002261 333-297233 261169844 33 2090
2026-07-02 S-3 S-3 0001193125-26-294457 333-297233 261150903 33 1180134 1 1
2026-05-26 S-8 S-8 0001193125-26-237305 333-296207 261015473 33 340352 1 1
2026-05-21 4 FORM 4 0001181186-26-000002 7930
2026-05-21 4 FORM 4 0001587788-26-000002 8035
2026-05-21 4 FORM 4 0001771423-26-000001 8105
2026-05-21 4 FORM 4 0001669080-26-000003 8043
2026-05-21 4 FORM 4 0001278219-26-000001 8103
2026-05-21 4 FORM 4 0001741836-26-000005 8031
2026-05-21 4 FORM 4 0001273306-26-000001 8034
2026-05-21 4 FORM 4 0001770390-26-000005 14850
2026-05-21 4 FORM 4 0001936799-26-000006 14819
2026-05-21 4 FORM 4 0001259780-26-000006 15485
2026-05-21 4 FORM 4 0001771498-26-000005 14871
2026-05-20 8-K 8-K 5.03,5.07,9.01 0001193125-26-232524 001-14888 261003845 34 174858 1 1
2026-05-18 4 FORM 4 0001771498-26-000004 9203
2026-05-18 4 FORM 4 0001259780-26-000005 9823
2026-05-18 4 FORM 4 0001770390-26-000004 9191
2026-05-18 4 FORM 4 0001936799-26-000005 9154
2026-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000919574-26-003181 005-60487 26981855 34 9977
2026-05-13 8-K 8-K 2.02,9.01 0001055726-26-000019 001-14888 26973278 34 262383 1 1
2026-05-13 10-Q 10-Q 0001055726-26-000018 001-14888 26973084 34 8216924 1 1
2026-05-13 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000919574-26-002915 005-60487 26971202 34 13460
2026-05-06 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000315066-26-001216 005-60487 26946807 34 11644
2026-04-07 DEF 14A DEF 14A 0001055726-26-000011 001-14888 26845039 34 8901309 1 1
2026-04-06 8-K 8-K 1.01,8.01,9.01 0001193125-26-142885 001-14888 26839545 34 808305 1 1
2026-04-02 424B5 424B5 0001193125-26-140421 333-275445 26834968 33 745916
2026-04-02 8-K 8-K 8.01 0001193125-26-138870 001-14888 26830512 34 136880 1 1
2026-04-02 424B5 424B5 0001193125-26-138636 333-275445 26830388 33 749033
2026-04-01 4 FORM 4 0001936799-26-000004 8923
2026-03-12 8-K 8-K 2.02,9.01 0001055726-26-000009 001-14888 26747688 34 271998 1 1
2026-03-12 10-K 10-K 0001055726-26-000008 001-14888 26747516 34 12070359 1 1
2026-03-05 4 FORM 4 0001770390-26-000003 8257
2026-03-05 4 FORM 4 0001771498-26-000003 8266
2026-03-05 4 FORM 4 0001936799-26-000003 8225
2026-03-05 4 FORM 4 0001259780-26-000004 8208
2026-02-27 4 FORM 4 0001770390-26-000002 14681
2026-02-27 4 FORM 4 0001259780-26-000002 15319
2026-02-27 4 FORM 4 0001771498-26-000002 14698
2026-02-27 4 FORM 4 0001936799-26-000002 12912
2026-02-27 4 FORM 4 0001669080-26-000002 7213
2026-02-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-26-001178 005-60487 26642744 34 11000
2026-01-30 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000102909-26-000224 005-60487 26582408 34 7433
2026-01-27 424B5 424B5 0001193125-26-024500 333-275445 26565728 33 45901
2026-01-27 8-K 8-K 1.01,3.03,9.01 0001193125-26-024431 001-14888 26565652 34 149645 1 1
2025-12-29 8-K 8-K 7.01,8.01,9.01 0001193125-25-332322 001-14888 251603277 34 164526 1 1
2025-12-08 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001274173-25-000337 005-60487 251555162 34 10376
2025-12-05 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000315066-25-002964 005-60487 251552356 34 11820
2025-11-14 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-25-005183 005-60487 251489000 34 10911
2025-11-14 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001274173-25-000276 005-60487 251482428 34 10934
2025-11-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-25-004827 005-60487 251481388 34 12363
2025-11-13 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-25-004899 005-60487 251475779 34 16972
2025-11-12 8-K 8-K 1.01,8.01,9.01 0001193125-25-275721 001-14888 251468387 34 451108 1 1
2025-11-12 424B5 424B5 0001193125-25-275689 333-275445 251468355 33 594043
2025-11-12 424B5 424B5 0001193125-25-274790 333-275445 251467826 33 595608
2025-11-10 8-K 8-K 2.02,9.01 0001055726-25-000064 001-14888 251466224 34 305826 1 1
2025-11-10 10-Q 10-Q 0001055726-25-000063 001-14888 251466019 34 8967317 1 1
2025-08-12 8-K 8-K 2.02,9.01 0001055726-25-000056 001-14888 251206708 34 323162 1 1
2025-08-12 10-Q 10-Q 0001055726-25-000055 001-14888 251206480 34 8755089 1 1
2025-07-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0002052113-25-003067 005-60487 251132230 34 11114
2025-07-07 8-K 8-K 1.01,8.01,9.01 0001193125-25-155830 001-14888 251106985 34 799770 1 1
2025-07-03 424B5 424B5 0001193125-25-155531 333-275445 251106296 33 629643
2025-07-02 424B5 424B5 0001193125-25-154972 333-275445 251101614 33 610746
2025-07-01 4 FORM 4 0001055726-25-000046 7284
2025-05-22 8-K 8-K 5.07 0001055726-25-000045 001-14888 25978251 34 178782 1 1
2025-05-21 4 FORM 4 0001055726-25-000042 8152
2025-05-21 4 FORM 4 0001055726-25-000041 8138
2025-05-21 4 FORM 4 0001055726-25-000040 7001
2025-05-21 4 FORM 4 0001055726-25-000039 7003
2025-05-21 4 FORM 4 0001055726-25-000038 6933
2025-05-21 4 FORM 4 0001055726-25-000037 6933
2025-05-21 4 FORM 4 0001055726-25-000036 6829
2025-05-21 4 FORM 4 0001055726-25-000035 8086
2025-05-21 4 FORM 4 0001055726-25-000034 6929
2025-05-21 4 FORM 4 0001055726-25-000033 8103
2025-05-21 4 FORM 4 0001055726-25-000032 6942
2025-05-16 4 FORM 4 0001055726-25-000031 9022
2025-05-16 4 FORM 4 0001055726-25-000030 9071
2025-05-16 4 FORM 4 0001055726-25-000029 9691
2025-05-16 4 FORM 4 0001055726-25-000028 9059
2025-05-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000935836-25-000331 005-60487 25945531 34 19592
2025-05-13 8-K 8-K 2.02,9.01 0001055726-25-000027 001-14888 25940063 34 275496 1 1
2025-05-13 10-Q 10-Q 0001055726-25-000026 001-14888 25939787 34 7856601 1 1
2025-05-12 4 FORM 4 0001055726-25-000020 9059
2025-04-30 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000932471-25-000647 005-60487 25892310 34 6531
2025-04-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001576419-25-000613 005-60487 25844585 34 11119
2025-04-07 ARS ARS 0001055726-25-000019 001-14888 25818348 34 18065108
2025-04-07 DEF 14A DEF 14A 0001055726-25-000018 001-14888 25818210 34 12713358 1 1
2025-03-18 8-K 8-K 2.02,9.01 0001055726-25-000013 001-14888 25748320 34 302096 1 1
2025-03-18 10-K 10-K 0001055726-25-000012 001-14888 25748097 34 12450086 1 1
2025-02-28 4 FORM 4 0001055726-25-000005 19392
2025-02-28 4 FORM 4 0001055726-25-000004 12049
2025-02-28 4 FORM 4 0001055726-25-000003 19411
2025-02-28 4 FORM 4 0001055726-25-000002 19883
2025-02-28 4 FORM 4 0001055726-25-000001 11364
2025-02-10 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-25-000808 005-60487 25606549 34 9864
2025-02-05 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0002012383-25-001479 005-60487 25594533 34 12095
2025-01-30 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000932471-25-000174 005-60487 25575651 34 6691
2024-12-23 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000935836-24-000779 005-60487 241575376 34 19847
2024-12-18 4 FORM 4 0001055726-24-000055 7941
2024-12-16 8-K 8-K 1.01,8.01,9.01 0001193125-24-279061 001-14888 241550200 34 539349 1 1
2024-12-13 424B5 424B5 0001193125-24-278461 333-275445 241548299 33 725063
2024-12-12 424B5 424B5 0001193125-24-277193 333-275445 241545649 33 726266
2024-11-14 8-K 8-K 2.02,9.01 0001055726-24-000053 001-14888 241462077 34 303943 1 1
2024-11-14 10-Q 10-Q 0001055726-24-000052 001-14888 241461503 34 8090284 1 1
2024-11-08 SC 13G us45773h4092_110824.txt 0002012383-24-003609 005-60487 241439770 34 13945
2024-10-22 SC 13G us45773h4092_102224.txt 0002012383-24-001669 005-60487 241387384 34 13933
2024-08-13 424B5 424B5 0001193125-24-199348 333-275445 241198671 33 402666
2024-08-13 8-K 8-K 1.01,9.01 0001193125-24-199331 001-14888 241198635 34 377895 1 1
2024-08-08 8-K 8-K 2.02,9.01 0001193125-24-197065 001-14888 241189439 34 252391 1 1
2024-08-08 10-Q 10-Q 0001055726-24-000046 001-14888 241188018 34 7896433 1 1
2024-07-01 4 FORM 4 0001055726-24-000042 7563
2024-05-28 8-K 8-K 5.02,5.07 0001193125-24-148076 001-14888 24991583 34 177218 1 1
2024-05-22 4 FORM 4 0001055726-24-000041 7939
2024-05-22 4 FORM 4 0001055726-24-000040 7871
2024-05-22 4 FORM 4 0001055726-24-000039 7941
2024-05-22 4 FORM 4 0001055726-24-000038 7879
2024-05-22 4 FORM 4 0001055726-24-000037 7766
2024-05-22 4 FORM 4 0001055726-24-000036 7870
2024-05-22 4 FORM 4 0001055726-24-000035 7867
2024-05-16 4 FORM 4 0001055726-24-000034 7236
2024-05-16 4 FORM 4 0001055726-24-000033 7167
2024-05-16 4 FORM 4 0001055726-24-000032 7166
2024-05-16 4 FORM 4 0001055726-24-000031 9866
2024-05-16 4 FORM 4 0001055726-24-000030 9338
2024-05-16 4 FORM 4 0001055726-24-000029 7560
2024-05-16 4 FORM 4 0001055726-24-000028 7175
2024-05-16 4 FORM 4 0001055726-24-000027 7061
2024-05-16 4 FORM 4 0001055726-24-000026 7234
2024-05-16 4 FORM 4 0001055726-24-000025 7160
2024-05-16 4 FORM 4 0001055726-24-000024 9350
2024-05-13 4 FORM 4 0001055726-24-000023 7400
2024-05-13 4 FORM 4 0001055726-24-000022 9338
2024-05-13 8-K 8-K 2.02,9.01 0001193125-24-137228 001-14888 24939164 34 247816 1 1
2024-05-13 10-Q 10-Q 0001055726-24-000020 001-14888 24938858 34 7132862 1 1
2024-04-26 SC 13G deeptrack-ino041624.htm 0001172661-24-001942 005-60487 24883383 34 105635
2024-04-17 8-K 8-K 1.01,8.01,9.01 0001193125-24-099067 001-14888 24850968 34 542786 1 1
2024-04-17 424B5 424B5 0001193125-24-099057 333-275445 24850947 33 732391
2024-04-15 ARS ARS 0001055726-24-000017 001-14888 24845533 34 18998569
2024-04-11 DEF 14A DEF 14A 0001055726-24-000014 001-14888 24838607 34 5066137
2024-03-06 10-K 10-K 0001055726-24-000011 001-14888 24725781 34 13182303 1 1
2024-02-28 4 FORM 4 0001055726-24-000006 15262
2024-02-28 4 FORM 4 0001055726-24-000005 19754
2024-02-28 4 FORM 4 0001055726-24-000004 19742
2024-02-28 4 FORM 4 0001055726-24-000003 20273
2024-02-28 4 FORM 4 0001055726-24-000002 8239
2024-02-13 SC 13G/A SCHEDULE 13G/A 0001104659-24-021192 005-60487 24628644 34 13387
2024-01-31 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2024-01-31 16:00:00 9999999995-24-000261 333-275445 24584884 33 2068
2024-01-29 CORRESP filename1.htm 0001193125-24-018179 8275
2024-01-26 S-3/A S-3/A 0001193125-24-016690 333-275445 24567680 33 107668
2024-01-25 8-K 8-K 5.03,9.01 0001193125-24-015380 001-14888 24562150 34 161600 1 1
2024-01-22 SC 13G/A Inovio_Pharma_Inc.txt 0000093751-24-000038 005-60487 24547356 34 8633
2024-01-12 8-K 8-K 5.07 0001193125-24-007674 001-14888 24532980 34 150533 1 1
2023-11-28 DEF 14A DEF 14A 0001193125-23-284277 001-14888 231446429 34 297183
2023-11-17 PRE 14A PRE 14A 0001193125-23-279764 001-14888 231418466 34 230060
2023-11-16 UPLOAD filename1.pdf 0000000000-23-012564 333-275445 40763
2023-11-09 S-3 S-3 0001193125-23-274556 333-275445 231393191 33 998559
2023-11-09 8-K 8-K 2.02,9.01 0001193125-23-274515 001-14888 231392675 34 256914 1 1
2023-11-09 10-Q 10-Q 0001055726-23-000055 001-14888 231392106 34 8640543 1 1
2023-11-02 8-K 8-K 3.01 0001193125-23-269347 001-14888 231372064 34 144990 1 1
2023-10-10 8-K 8-K 7.01,8.01,9.01 0001193125-23-253450 001-14888 231317892 34 176332 1 1
2023-08-09 8-K 8-K 2.02,9.01 0001193125-23-207397 001-14888 231155559 34 253626 1 1
2023-08-09 10-Q 10-Q 0001055726-23-000051 001-14888 231154960 34 8563279 1 1
2023-08-01 8-K 8-K 2.05 0001193125-23-199683 001-14888 231129346 34 144146 1 1
2023-07-10 SC 13G/A Inovio_Pharma_Inc.txt 0000093751-23-000630 005-60487 231079337 34 8519
2023-07-07 SC 13G/A us45773h2013_070723.txt 0001306550-23-009603 005-60487 231077290 34 12620
2023-07-03 4 FORM 4 0001055726-23-000045 7171
2023-06-23 8-K 8-K 7.01,9.01 0001193125-23-173847 001-14888 231038042 34 448673 1 1
2023-06-05 4 FORM 4 0001055726-23-000044 4880
2023-06-05 144 xsl144X01/primary_doc.xml 0001950047-23-001252 001-14888 23992351 33 5034
2023-05-18 S-8 S-8 0001193125-23-148226 333-272047 23936725 33 64742
2023-05-18 S-8 S-8 0001193125-23-148215 333-272045 23936616 33 81307
2023-05-18 8-K 8-K 5.02,5.07,9.01 0001193125-23-148122 001-14888 23936084 34 339396 1 1
2023-05-17 4 FORM 4 0001055726-23-000043 5939
2023-05-17 4 FORM 4 0001055726-23-000042 5978
2023-05-17 4 FORM 4 0001055726-23-000041 5780
2023-05-17 4 FORM 4 0001055726-23-000040 5984
2023-05-16 4 FORM 4 0001055726-23-000039 11395
2023-05-16 4 FORM 4 0001055726-23-000038 11222
2023-05-16 4 FORM 4 0001055726-23-000037 11335
2023-05-16 4 FORM 4 0001055726-23-000036 11327
2023-05-16 4 FORM 4 0001055726-23-000035 11327
2023-05-16 4 FORM 4 0001055726-23-000034 11397
2023-05-16 4 FORM 4 0001055726-23-000033 15115
2023-05-12 4 FORM 4 0001055726-23-000032 8896
2023-05-10 8-K 8-K 2.02,9.01 0001193125-23-140755 001-14888 23906716 34 261752 1 1
2023-05-10 10-Q 10-Q 0001055726-23-000030 001-14888 23906219 34 8465106 1 1
2023-04-03 EFFECT xslEFFECTX01/primary_doc.xml POS AM,0001193125-23-056527,2023-04-03 9999999995-23-000798 333-252256 23794987 33 2009
2023-03-31 DEFA14A DEFA14A 0001055726-23-000025 001-14888 23788221 34 201425
2023-03-28 ARS ARS 0001055726-23-000023 001-14888 23770321 34 87748923
2023-03-28 DEF 14A DEF 14A 0001055726-23-000022 001-14888 23770298 34 3397411
2023-03-28 POS EX POS EX 0001193125-23-082177 333-252256 23769709 33 69101
2023-03-13 4 FORM 4 0001055726-23-000014 8722
2023-03-13 4 FORM 4 0001055726-23-000013 8932
2023-03-13 4 FORM 4 0001055726-23-000012 8935
2023-03-13 4 FORM 4 0001055726-23-000011 9415
2023-03-01 POS AM POS AM 0001193125-23-056527 333-252256 23694786 33 300828
2023-03-01 10-K 10-K 0001055726-23-000010 001-14888 23694199 34 14101521 1 1
2023-03-01 POSASR POSASR 0001193125-23-056386 333-252256 23694055 33 339329
2023-03-01 8-K 8-K 2.02,9.01 0001193125-23-056363 001-14888 23693864 34 267311 1 1
2023-02-28 4 FORM 4 0001055726-23-000007 16828
2023-02-28 4 FORM 4 0001055726-23-000006 16820
2023-02-28 4 FORM 4 0001055726-23-000005 17306
2023-02-28 4 FORM 4 0001055726-23-000004 17405
2023-02-28 4 FORM 4 0001055726-23-000003 5703
2023-02-09 SC 13G/A Inovio_Pharmaceuticals_Inc.txt 0000093751-23-000396 005-60487 23605785 34 10679
2023-02-09 SC 13G/A SCHEDULE 13G/A 0001104659-23-016201 005-60487 23603460 34 13290
2023-01-31 8-K 8-K 2.05,7.01,8.01,9.01 0001193125-23-019738 001-14888 23570285 34 182274 1 1
2023-01-24 SC 13G/A us45773h2013_012423.txt 0001306550-23-003092 005-60487 23547482 34 13673
2023-01-17 4 FORM 4 0001055726-23-000001 7102
2022-11-08 8-K 8-K 2.02,9.01 0001193125-22-280159 001-14888 221369047 34 247687 1 1
2022-11-08 10-Q 10-Q 0001055726-22-000055 001-14888 221368712 34 9417057 1 1
2022-10-14 UPLOAD filename1.pdf 0000000000-22-011338 40001
2022-09-29 CORRESP filename1.htm 0001193125-22-254501 56175
2022-09-15 UPLOAD filename1.pdf 0000000000-22-010123 45304
2022-08-11 4 FORM 4 0001055726-22-000050 9004
2022-08-09 8-K 8-K 2.02,9.01 0001193125-22-216168 001-14888 221148611 34 257170 1 1
2022-08-09 10-Q 10-Q 0001055726-22-000049 001-14888 221148053 34 9554265 1 1
2022-07-20 4 FORM 4 0001055726-22-000045 8478
2022-07-19 8-K 8-K 2.05,7.01,9.01 0001193125-22-196671 001-14888 221090474 34 179104 1 1
2022-07-06 4 FORM 4 0001055726-22-000044 8128
2022-07-06 3 FORM 3 0001055726-22-000043 3357
2022-06-30 S-8 S-8 0001193125-22-186278 333-265944 221058700 33 317963
2022-05-17 8-K 8-K 5.02,5.07 0001193125-22-153110 001-14888 22935461 34 162018 1 1
2022-05-17 4 FORM 4 0001055726-22-000042 11585
2022-05-17 4 FORM 4 0001055726-22-000041 13067
2022-05-17 4 FORM 4 0001055726-22-000040 11346
2022-05-17 4 FORM 4 0001055726-22-000039 12971
2022-05-17 4 FORM 4 0001055726-22-000038 11345
2022-05-17 4 FORM 4 0001055726-22-000037 11416
2022-05-17 4 FORM 4 0001055726-22-000036 11241
2022-05-11 4 FORM 4 0001055726-22-000035 8157
2022-05-11 DEFA14A DEFA14A 0001193125-22-147190 001-14888 22912753 34 16565
2022-05-10 8-K 8-K 2.02,5.02,7.01,9.01 0001193125-22-146350 001-14888 22910173 34 282174 1 1
2022-05-10 10-Q 10-Q 0001055726-22-000034 001-14888 22909382 34 8571959 1 1
2022-04-11 SC 13G/A Inovio_Pharmaceuticals_Inc.txt 0000093751-22-000492 005-60487 22819339 34 10665
2022-03-28 4 FORM 4 0001055726-22-000031 8942
2022-03-25 DEF 14A DEF 14A 0001055726-22-000030 001-14888 22771786 34 4107088
2022-03-22 4 FORM 4 0001055726-22-000026 7169
2022-03-17 4 FORM 4 0001055726-22-000025 8477
2022-03-14 4 FORM 4 0001055726-22-000024 8948
2022-03-14 4 FORM 4 0001055726-22-000023 8948
2022-03-14 4 FORM 4 0001055726-22-000022 8949
2022-03-14 4 FORM 4 0001055726-22-000021 9343
2022-03-14 4 FORM 4 0001055726-22-000020 12373
2022-03-14 4 FORM 4 0001055726-22-000019 9431
2022-03-09 4 FORM 4 0001055726-22-000017 9420
2022-03-09 4 FORM 4 0001055726-22-000016 12356
2022-03-09 4 FORM 4 0001055726-22-000015 8937
2022-03-09 4 FORM 4 0001055726-22-000014 8865
2022-03-01 4 FORM 4 0001055726-22-000013 11989
2022-03-01 4 FORM 4 0001055726-22-000012 14266
2022-03-01 4 FORM 4 0001055726-22-000011 13778
2022-03-01 4 FORM 4 0001055726-22-000010 13784
2022-03-01 4 FORM 4 0001055726-22-000009 17209
2022-03-01 S-8 S-8 0001193125-22-061610 333-263167 22699526 33 68000
2022-03-01 10-K 10-K 0001055726-22-000008 001-14888 22697793 34 16421844 1 1
2022-02-11 SC 13G/A INOVIO_PHARMACEUTICALS_INC.txt 0000093751-22-000264 005-60487 22618113 34 8749
2022-02-10 SC 13G/A SCHEDULE 13G/A 0001104659-22-017814 005-60487 22610021 34 13285
2022-02-01 SC 13G/A us45773h2013_020122.txt 0000834237-22-004599 005-60487 22580034 34 13702
2022-01-21 4 FORM 4 0001055726-22-000003 8477
2022-01-18 4 FORM 4 0001055726-22-000002 7108
2022-01-05 4 FORM 4 0001055726-22-000001 8723
2021-11-09 424B5 424B5 0001193125-21-324567 333-252256 211392919 33 252280
2021-11-09 10-Q 10-Q 0001055726-21-000062 001-14888 211391883 34 10657486 1 1
2021-10-29 8-K 8-K 1.02 0001193125-21-313502 001-14888 211364083 34 146218 1 1
2021-10-28 8-K 8-K 7.01 0001193125-21-310286 001-14888 211354918 34 145642 1 1
2021-08-11 4 FORM 4 0001055726-21-000056 5436
2021-08-09 10-Q 10-Q 0001055726-21-000055 001-14888 211156337 34 10303191 1 1
2021-06-11 4 FORM 4 0001055726-21-000052 5442
2021-06-11 4 FORM 4 0001055726-21-000051 5436
2021-06-11 4 FORM 4 0001055726-21-000050 9298
2021-06-11 8-K 8-K 1.01,7.01,9.01 0001193125-21-188845 001-14888 211011217 34 192468 1 1
2021-06-04 4 FORM 4 0001055726-21-000049 5919
2021-05-17 4 FORM 4 0001055726-21-000048 11413
2021-05-17 4 FORM 4 0001055726-21-000047 12968
2021-05-17 4 FORM 4 0001055726-21-000046 11343
2021-05-17 4 FORM 4 0001055726-21-000045 13065
2021-05-17 4 FORM 4 0001055726-21-000044 12899
2021-05-17 4 FORM 4 0001055726-21-000043 11238
2021-05-17 4 FORM 4 0001055726-21-000042 8207
2021-05-17 3 FORM 3 0001055726-21-000041 3284
2021-05-17 8-K 8-K 5.02,5.07,7.01,9.01 0001193125-21-163719 001-14888 21930980 34 202516 1 1
2021-05-10 10-Q 10-Q 0001055726-21-000040 001-14888 21906854 34 8964433 1 1
2021-04-21 4 FORM 4 0001055726-21-000037 5919
2021-04-21 4 FORM 4 0001055726-21-000036 10669
2021-04-16 4 FORM 4 0001055726-21-000035 8475
2021-03-26 4 FORM 4 0001055726-21-000034 10506
2021-03-25 DEF 14A DEF 14A 0001055726-21-000033 001-14888 21773537 34 952717
2021-03-23 4 FORM 4 0001055726-21-000030 7175
2021-03-16 4 FORM 4 0001055726-21-000028 8479
2021-03-12 4 FORM 4 0001055726-21-000027 9436
2021-03-12 4 FORM 4 0001055726-21-000026 8952
2021-03-12 4 FORM 4 0001055726-21-000025 7166
2021-03-12 4 FORM 4 0001055726-21-000024 12377
2021-03-12 4 FORM 4 0001055726-21-000023 11136
2021-03-09 4 FORM 4 0001055726-21-000022 17897
2021-03-09 4 FORM 4 0001055726-21-000021 14466
2021-03-09 4 FORM 4 0001055726-21-000020 14115
2021-03-09 4 FORM 4 0001055726-21-000019 14951
2021-03-01 S-8 S-8 0001193125-21-063786 333-253736 21699138 33 61911
2021-03-01 8-K 8-K 2.02,7.01,9.01 0001193125-21-063569 001-14888 21698270 34 356544 1 1
2021-03-01 10-K 10-K 0001055726-21-000018 001-14888 21697536 34 18614587 1 1
2021-02-26 4 FORM 4 0001055726-21-000015 8086
2021-02-26 4 FORM 4 0001055726-21-000014 7983
2021-02-26 4 FORM 4 0001055726-21-000013 8143
2021-02-26 4 FORM 4 0001055726-21-000012 8185
2021-02-26 4 FORM 4 0001055726-21-000011 8188
2021-02-18 4 FORM 4 0001055726-21-000009 8479
2021-02-11 SC 13G/A SC 13G/A 0001140361-21-004328 005-60487 21619558 34 72271
2021-02-11 SC 13G/A ino221.txt 0000814133-21-000062 005-60487 21618855 34 4264
2021-02-10 SC 13G/A SCHEDULE 13G/A 0001104659-21-018351 005-60487 21611086 34 14150
2021-02-10 SC 13G Inovio_Pharmaceuticals_Inc.txt 0000093751-21-000182 005-60487 21609444 34 8765
2021-02-05 SC 13G/A AMENDMENT NO. 1 0001214659-21-001373 005-60487 21593353 34 63478
2021-02-03 4 FORM 4 0001055726-21-000008 13875
2021-02-03 4 FORM 4 0001055726-21-000007 10684
2021-01-29 4 FORM 4 0001055726-21-000005 15928
2021-01-29 SC 13G/A us45773h2013_012921.txt 0000834237-21-003989 005-60487 21568845 34 13683
2021-01-22 8-K 8-K 1.01,8.01,9.01 0001193125-21-014758 001-14888 21546024 34 450227 1 1
2021-01-22 424B5 424B5 0001193125-21-014750 333-252256 21546008 33 624204
2021-01-20 8-K 8-K 2.02,8.01,9.01 0001193125-21-012455 001-14888 21539042 34 427476 1 1
2021-01-20 424B5 424B5 0001193125-21-012445 333-252256 21539008 33 616239
2021-01-20 S-3ASR S-3ASR 0001193125-21-012393 333-252256 21538773 33 188437
2021-01-15 4 FORM 4 0001055726-21-000004 9540
2021-01-15 4 FORM 4 0001055726-21-000003 7113
2021-01-05 4 FORM 4 0001055726-21-000002 8732
2021-01-05 4 FORM 4 0001055726-21-000001 8475
2021-01-04 8-K 8-K 1.01,7.01,9.01 0001193125-21-000955 001-14888 21501904 34 203370 1 1
2020-12-31 4 FORM 4 0001055726-20-000057 8491
2020-12-17 4 FORM 4 0001055726-20-000056 13029
2020-12-17 4 FORM 4 0001055726-20-000055 8963
2020-12-07 4 FORM 4 0001055726-20-000054 7002
2020-11-16 8-K 8-K 8.01,9.01 0001193125-20-294751 001-14888 201316773 34 188412 1 1
2020-11-12 4 FORM 4 0001055726-20-000053 5436
2020-11-09 10-Q 10-Q 0001055726-20-000052 001-14888 201297475 34 10699726 1 1
2020-10-15 8-K 8-K 1.02 0001193125-20-270257 001-14888 201241530 34 145377 1 1
2020-09-28 8-K 8-K 8.01,9.01 0001193125-20-256781 001-14888 201205406 34 179623 1 1
2020-09-03 8-K 8-K 5.02 0001193125-20-239111 001-14888 201159731 34 154903 1 1
2020-08-12 4 FORM 4 0001055726-20-000049 5441
2020-08-10 10-Q 10-Q 0001055726-20-000048 001-14888 201089118 34 10483107 1 1
2020-07-31 4 FORM 4 0001055726-20-000045 8860
2020-07-17 4 FORM 4 0001055726-20-000044 9540
2020-07-02 4 FORM 4 0001055726-20-000043 5923
2020-06-25 8-K 8-K 1.01,7.01,8.01,9.01 0001193125-20-179128 001-14888 20989850 34 60183
2020-06-24 4 FORM 4 0001055726-20-000042 4968
2020-06-03 8-K 8-K 8.01 0001193125-20-159486 001-14888 20939950 34 23588
2020-05-20 4 FORM 4 0001055726-20-000040 8748
2020-05-18 8-K 8-K 5.07 0001193125-20-145017 001-14888 20889529 34 28617
2020-05-15 4 FORM 4 0001055726-20-000039 7794
2020-05-15 4 FORM 4 0001055726-20-000038 7856
2020-05-15 4 FORM 4 0001055726-20-000037 7854
2020-05-15 4 FORM 4 0001055726-20-000036 7785
2020-05-15 4 FORM 4 0001055726-20-000035 7681
2020-05-15 4 FORM 4 0001055726-20-000034 7786
2020-05-12 8-K 8-K 8.01,9.01 0001193125-20-140512 001-14888 20869596 34 34645
2020-05-12 4 FORM 4 0001055726-20-000033 5027
2020-05-12 424B5 424B5 0001193125-20-140456 333-237172 20869418 33 367042
2020-05-11 10-Q 10-Q 0001055726-20-000032 001-14888 20864609 34 6932894 1
2020-05-08 4 FORM 4 0001055726-20-000029 6859
2020-05-08 4 FORM 4 0001055726-20-000028 6928
2020-05-08 4 FORM 4 0001055726-20-000027 6755
2020-05-08 4 FORM 4 0001055726-20-000026 6869
2020-05-08 4 FORM 4 0001055726-20-000025 6930
2020-05-08 4 FORM 4 0001055726-20-000024 6853
2020-05-01 UPLOAD filename1.pdf 0000000000-20-003771 39987
2020-04-24 CORRESP filename1.htm 0001193125-20-119137 24441
2020-04-15 DEFA14A DEFA14A 0001193125-20-108190 001-14888 20794352 34 46248
2020-04-14 UPLOAD filename1.pdf 0000000000-20-003215 43121
2020-04-06 8-K FORM 8-K 8.01 0001193125-20-099003 001-14888 20775854 34 19037
2020-04-03 8-K 8-K 1.01,8.01,9.01 0001193125-20-098305 001-14888 20774501 34 178742
2020-04-03 424B5 424B5 0001193125-20-098301 333-237172 20774468 33 377045
2020-03-31 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2020-03-31 16:00:00 9999999995-20-000654 333-237172 20763609 33 1996
2020-03-27 CORRESP filename1.htm 0001193125-20-088806 21092
2020-03-27 DEF 14A DEF 14A 0001055726-20-000022 001-14888 20751779 34 991399
2020-03-26 4 FORM 4 0001055726-20-000019 8952

Latest XBRL company facts

One latest value per concept from companyfacts (441 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 187.31M 2026-11-10 2026 Q3 10-Q 2026-11-10 0001055726-26-000029
dei EntityPublicFloat Entity Public Float USD 74.30M 2025-06-30 2025 FY 10-K 2026-03-12 0001055726-26-000008
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 833,484 2025-01-01 2025-12-31 DEF 14A 2026-04-07 0001055726-26-000011
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 872,160 2025-01-01 2025-12-31 DEF 14A 2026-04-07 0001055726-26-000011
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 9.29 2025-01-01 2025-12-31 DEF 14A 2026-04-07 0001055726-26-000011
ffd NetFeeAmt NetFeeAmt USD 36,318.61 2026-06-30 S-3 2026-07-02 0001193125-26-294457
ffd TtlFeeAmt TtlFeeAmt USD 36,318.61 2026-06-30 S-3 2026-07-02 0001193125-26-294457
ffd TtlOfferingAmt TtlOfferingAmt USD 300.00M 2026-06-30 S-3 2026-07-02 0001193125-26-294457
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-06-30 S-3 2026-07-02 0001193125-26-294457
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 0 2026-06-30 S-3 2026-07-02 0001193125-26-294457
us-gaap AccountsPayableAndAccruedLiabilitiesCurrent Accounts Payable and Accrued Liabilities, Current USD 24.75M 2023-03-31 2023 Q1 10-Q 2023-05-10 0001055726-23-000030
us-gaap AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent Accounts Payable and Accrued Liabilities USD 23.13M 2018-12-31 2018 FY 10-K 2019-03-12 0001055726-19-000012
us-gaap AccountsPayableTradeCurrentAndNoncurrent Accounts Payable, Trade USD 11.19M 2023-03-31 2023 Q1 10-Q 2023-05-10 0001055726-23-000030
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 450 2025-12-31 2025 FY 10-K 2026-03-12 0001055726-26-000008
us-gaap AccountsReceivableRelatedPartiesCurrent Accounts Receivable, Related Parties, Current USD 4.96M 2023-03-31 2023 Q1 10-Q 2023-05-10 0001055726-23-000030
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 4.50M 2019-09-30 2019 Q3 10-Q 2019-11-12 0001055726-19-000058
us-gaap AccruedLiabilitiesForCommissionsExpenseAndTaxes Accrued Liabilities for Commissions, Expense and Taxes USD 162.10M 2021-01-25 2021 Q3 10-Q 2021-11-09 0001055726-21-000062
us-gaap AccruedProfessionalFeesCurrentAndNoncurrent Accrued Professional Fees USD 177,810 2012-12-31 2012 FY 10-K 2013-03-18 0001445305-13-000665
us-gaap AccruedSalariesCurrent Accrued Salaries, Current USD 7.61M 2023-03-31 2023 Q1 10-Q 2023-05-10 0001055726-23-000030
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 17.42M 2025-12-31 2025 FY 10-K 2026-03-12 0001055726-26-000008
us-gaap AccumulatedDepreciationDepletionAndAmortizationSaleOfPropertyPlantAndEquipment1 Accumulated Depreciation, Depletion and Amortization, Sale or Disposal of Property, Plant and Equipment USD 89,000 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-01 0001055726-22-000008
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -267,070 2026-09-30 2026 Q3 10-Q 2026-11-10 0001055726-26-000029
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 1.86B 2026-09-30 2026 Q3 10-Q 2026-11-10 0001055726-26-000029
us-gaap AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt USD 15.75M 2019-01-01 2019-12-31 2021 FY 10-K 2022-03-01 0001055726-22-000008
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 868,002 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001055726-26-000029
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 3.03M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001055726-26-000029
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 3.70M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001055726-26-000008
us-gaap AllowanceForDoubtfulAccountsReceivableCurrent Accounts Receivable, Allowance for Credit Loss, Current USD 0 2025-12-31 2025 FY 10-K 2026-03-12 0001055726-26-000008
us-gaap AmortizationOfIntangibleAssets Amortization of Intangible Assets USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-18 0001055726-25-000012
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 99.52M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001055726-26-000029
us-gaap Assets Assets USD 60.14M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001055726-26-000029
us-gaap AssetsCurrent Assets, Current USD 51.44M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001055726-26-000029
us-gaap AssetsFairValueDisclosure Assets, Fair Value Disclosure USD 16.34M 2025-12-31 2026 Q3 10-Q 2026-11-10 0001055726-26-000029
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 2,534 2026-09-30 2026 Q3 10-Q 2026-11-10 0001055726-26-000029
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 28,319 2026-09-30 2026 Q3 10-Q 2026-11-10 0001055726-26-000029
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 1.42M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001055726-26-000029
us-gaap AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax Available-for-sale Equity Securities, Accumulated Gross Unrealized Gain, before Tax USD 2.33M 2017-12-31 2018 Q3 10-Q 2018-11-08 0001055726-18-000045
us-gaap AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax Available-for-sale Equity Securities, Accumulated Gross Unrealized Loss, before Tax USD 0 2017-12-31 2018 Q3 10-Q 2018-11-08 0001055726-18-000045
us-gaap AvailableForSaleEquitySecuritiesAmortizedCostBasis Available-for-sale Equity Securities, Amortized Cost Basis USD 0 2015-06-30 2019 Q2 10-Q 2019-08-08 0001055726-19-000052
us-gaap AvailableForSaleSecurities Available-for-sale Securities USD 105.96M 2017-12-31 2018 FY 10-K 2019-03-12 0001055726-19-000012
us-gaap AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax USD 2.37M 2017-12-31 2018 FY 10-K 2019-03-12 0001055726-19-000012
us-gaap AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax USD 392,571 2017-12-31 2018 FY 10-K 2019-03-12 0001055726-19-000012
us-gaap AvailableForSaleSecuritiesAmortizedCost Available-for-sale Securities, Amortized Cost Basis USD 103.99M 2017-12-31 2018 FY 10-K 2019-03-12 0001055726-19-000012
us-gaap AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAggregateLosses Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Aggregate Loss (Deprecated 2018-01-31) USD 108,000 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-14 0001055726-18-000014
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 1.40M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001055726-26-000029
us-gaap AvailableForSaleSecuritiesEquitySecurities Available-for-sale Securities, Equity Securities USD 2.33M 2017-12-31 2018 Q3 10-Q 2018-11-08 0001055726-18-000045
us-gaap AvailableForSaleSecuritiesEquitySecuritiesNoncurrent Available-for-sale Securities, Equity Securities, Noncurrent USD 0 2016-12-31 2016 FY 10-K 2017-03-15 0001055726-17-000013
us-gaap AvailableForSaleSecuritiesFairValueDisclosure Available-for-sale Securities, Fair Value Disclosure (Deprecated 2013-01-31) USD 13.11M 2013-06-30 2013 Q2 10-Q 2013-08-09 0001055726-13-000008
us-gaap AvailableforsaleSecuritiesGrossUnrealizedGain Available-for-sale Securities, Gross Unrealized Gains (Deprecated 2013-01-31) USD 0 2013-06-30 2013 Q2 10-Q 2013-08-09 0001055726-13-000008
us-gaap AvailableForSaleSecuritiesGrossUnrealizedLosses1 Available-for-sale Securities, Gross Unrealized Losses (Deprecated 2013-01-31) USD 84,185 2013-06-30 2013 Q2 10-Q 2013-08-09 0001055726-13-000008
us-gaap AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositions1 Available-for-sale, Securities in Unrealized Loss Positions, Qualitative Disclosure, Number of Positions investment 42 2017-12-31 2017 FY 10-K 2018-03-14 0001055726-18-000014
us-gaap AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsGreaterThanOrEqualToOneYear Available-for-sale, Securities in Unrealized Loss Positions, Qualitative Disclosure, Number of Positions, Greater than or Equal to One Year investment 16 2017-12-31 2017 FY 10-K 2018-03-14 0001055726-18-000014
us-gaap Capital Banking Regulation, Total Capital, Actual USD 255.30M 2022-09-30 2022 Q3 10-Q 2022-11-08 0001055726-22-000055
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 0 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-12 0001055726-26-000023
us-gaap CashAcquiredFromAcquisition Cash Acquired from Acquisition USD 1.61M 2009-01-01 2009-12-31 2011 FY 10-K 2012-03-15 0001193125-12-117292
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 46.96M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001055726-26-000029
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD -92,946 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-12 0001055726-19-000012
us-gaap CashCashEquivalentsAndShortTermInvestments Cash, Cash Equivalents, and Short-term Investments USD 48.40M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001055726-26-000029
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 46.96M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001055726-26-000029
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 2.69M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001055726-26-000029
us-gaap CashDivestedFromDeconsolidation Cash Divested from Deconsolidation USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-01 0001055726-23-000010
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights Class of Warrant or Right, Exercise Price of Warrants or Rights (Deprecated 2014-01-31) USD/warrant 1.4 2011-01-31 2013 FY 10-K 2014-03-17 0001055726-14-000003
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 1.4 2026-04-06 2026 Q3 10-Q 2026-11-10 0001055726-26-000029
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 94.08M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001055726-26-000029
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-10 0001055726-26-000029
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 600.00M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001055726-26-000029
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 110.18M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001055726-26-000029
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 110.18M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001055726-26-000029
us-gaap CommonStockValue Common Stock, Value, Issued USD 110,182 2026-09-30 2026 Q3 10-Q 2026-11-10 0001055726-26-000029
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -74.53M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001055726-26-000029
us-gaap ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-01 0001055726-23-000010
us-gaap ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest USD -110.17M 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-09 0001055726-23-000055
us-gaap ContractWithCustomerLiabilityCurrent Contract with Customer, Liability, Current USD 0 2022-12-31 2022 FY 10-K 2023-03-01 0001055726-23-000010
us-gaap ContractWithCustomerLiabilityNoncurrent Contract with Customer, Liability, Noncurrent USD 0 2022-12-31 2022 FY 10-K 2023-03-01 0001055726-23-000010
us-gaap ContractWithCustomerLiabilityRevenueRecognized Contract with Customer, Liability, Revenue Recognized USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-18 0001055726-25-000012
us-gaap ConvertibleDebt Convertible Debt USD 16.30M 2022-09-30 2022 Q3 10-Q 2022-11-08 0001055726-22-000055
us-gaap ConvertibleDebtCurrent Convertible Debt, Current USD 0 2024-12-31 2024 FY 10-K 2025-03-18 0001055726-25-000012
us-gaap ConvertibleDebtNoncurrent Convertible Debt, Noncurrent USD 0 2023-12-31 2023 FY 10-K 2024-03-06 0001055726-24-000011
us-gaap CostMethodInvestmentsFairValueDisclosure Cost Method Investments, Fair Value Disclosure USD 2.33M 2017-12-31 2017 FY 10-K 2018-03-14 0001055726-18-000014
us-gaap CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption Cumulative Effect of New Accounting Principle in Period of Adoption (Deprecated 2020-01-31) USD 0 2018-01-01 2019 FY 10-K 2020-03-12 0001055726-20-000012
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-01 0001055726-21-000018
us-gaap CurrentForeignTaxExpenseBenefit Current Foreign Tax Expense (Benefit) USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-01 0001055726-21-000018
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-01 0001055726-21-000018
us-gaap CurrentStateAndLocalTaxExpenseBenefit Current State and Local Tax Expense (Benefit) USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-01 0001055726-21-000018
us-gaap DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent Debt Instrument, Convertible, Carrying Amount of Equity Component USD 62.20M 2020-03-31 2020 Q1 10-Q 2020-05-11 0001055726-20-000032
us-gaap DebtInstrumentConvertibleConversionPrice1 Debt Instrument, Convertible, Conversion Price USD/shares 5.38 2020-03-31 2020 Q1 10-Q 2020-05-11 0001055726-20-000032
us-gaap DebtInstrumentConvertibleThresholdConsecutiveTradingDays1 Debt Instrument, Convertible, Threshold Consecutive Trading Days day 30 2020-01-01 2020-03-31 2020 Q1 10-Q 2020-05-11 0001055726-20-000032
us-gaap DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger pure 1.3 2020-01-01 2020-06-30 2020 Q2 10-Q 2020-08-10 0001055726-20-000048
us-gaap DebtInstrumentConvertibleThresholdTradingDays Debt Instrument, Convertible, Threshold Trading Days day 20 2020-01-01 2020-03-31 2020 Q1 10-Q 2020-05-11 0001055726-20-000032
us-gaap DebtInstrumentInterestRateEffectivePercentage Debt Instrument, Interest Rate, Effective Percentage pure 0.131 2019-12-31 2019 FY 10-K 2020-03-12 0001055726-20-000012
us-gaap DebtInstrumentRedemptionPricePercentage Debt Instrument, Redemption Price, Percentage pure 1 2020-01-01 2020-03-31 2020 Q1 10-Q 2020-05-11 0001055726-20-000032
us-gaap DebtInstrumentUnamortizedDiscount Debt Instrument, Unamortized Discount USD 18.60M 2019-12-31 2019 FY 10-K 2020-03-12 0001055726-20-000012
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer USD 31,000 2019-03-31 2019 Q1 10-Q 2019-05-09 0001055726-19-000029
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss USD 560,000 2020-03-31 2020 Q1 10-Q 2020-05-11 0001055726-20-000032
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Number of Positions position 19 2024-06-30 2024 Q2 10-Q 2024-08-08 0001055726-24-000046
us-gaap DebtSecuritiesAvailableForSaleRealizedGain Debt Securities, Available-for-sale, Realized Gain USD 400 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001055726-26-000029
us-gaap DebtSecuritiesAvailableForSaleRealizedGainLoss Debt Securities, Available-for-sale, Realized Gain (Loss) USD 238,000 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-12 0001055726-19-000058
us-gaap DebtSecuritiesAvailableForSaleRealizedLoss Debt Securities, Available-for-sale, Realized Loss USD 1.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001055726-26-000029
us-gaap DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions position 2 2026-09-30 2026 Q3 10-Q 2026-11-10 0001055726-26-000029
us-gaap DeconsolidationGainOrLossAmount Deconsolidation, Gain (Loss), Amount USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-01 0001055726-23-000010
us-gaap DeferredFederalIncomeTaxExpenseBenefit Deferred Federal Income Tax Expense (Benefit) USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-01 0001055726-21-000018
us-gaap DeferredFinanceCostsNet Debt Issuance Costs, Net USD 2.80M 2020-03-31 2020 Q1 10-Q 2020-05-11 0001055726-20-000032
us-gaap DeferredForeignIncomeTaxExpenseBenefit Deferred Foreign Income Tax Expense (Benefit) USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-01 0001055726-21-000018
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-18 0001055726-25-000012
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 1.37M 2025-12-31 2025 FY 10-K 2026-03-12 0001055726-26-000008
us-gaap DeferredIncomeTaxLiabilitiesNet Deferred Income Tax Liabilities, Net USD 0 2023-12-31 2023 FY 10-K 2024-03-06 0001055726-24-000011
us-gaap DeferredRentCreditCurrent Deferred Rent Credit, Current USD 0 2019-12-31 2019 FY 10-K 2020-03-12 0001055726-20-000012
us-gaap DeferredRentCreditNoncurrent Deferred Rent Credit, Noncurrent USD 0 2019-12-31 2019 FY 10-K 2020-03-12 0001055726-20-000012
us-gaap DeferredRevenue Deferred Revenue USD 2.40M 2012-12-31 2012 FY 10-K 2013-03-18 0001445305-13-000665
us-gaap DeferredRevenueCurrent Deferred Revenue, Current USD 651,505 2026-09-30 2026 Q3 10-Q 2026-11-10 0001055726-26-000029
us-gaap DeferredRevenueNoncurrent Deferred Revenue, Noncurrent USD 203,322 2018-03-31 2018 Q1 10-Q 2018-05-09 0001055726-18-000026
us-gaap DeferredStateAndLocalIncomeTaxExpenseBenefit Deferred State and Local Income Tax Expense (Benefit) USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-01 0001055726-21-000018
us-gaap DeferredTaxAssetsDeferredIncome Deferred Tax Assets, Deferred Income USD 0 2024-12-31 2024 FY 10-K 2025-03-18 0001055726-25-000012
us-gaap DeferredTaxAssetsDerivativeInstruments Deferred Tax Assets, Derivative Instruments USD 0 2020-12-31 2020 FY 10-K 2021-03-01 0001055726-21-000018
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 379.85M 2025-12-31 2025 FY 10-K 2026-03-12 0001055726-26-000008
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 40.30M 2025-12-31 2025 FY 10-K 2026-03-12 0001055726-26-000008
us-gaap DeferredTaxAssetsInvestments Deferred Tax Assets, Investments USD 1.55M 2025-12-31 2025 FY 10-K 2026-03-12 0001055726-26-000008
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 1.37M 2025-12-31 2025 FY 10-K 2026-03-12 0001055726-26-000008
us-gaap DeferredTaxAssetsNetCurrent Deferred Tax Assets, Net of Valuation Allowance, Current USD 0 2015-12-31 2015 FY 10-K 2016-03-14 0001055726-16-000033
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 293.03M 2025-12-31 2025 FY 10-K 2026-03-12 0001055726-26-000008
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 5.72M 2025-12-31 2025 FY 10-K 2026-03-12 0001055726-26-000008
us-gaap DeferredTaxAssetsOtherTaxCarryforwards Deferred Tax Assets, Other Tax Carryforwards USD 33.51M 2025-12-31 2025 FY 10-K 2026-03-12 0001055726-26-000008
us-gaap DeferredTaxAssetsPropertyPlantAndEquipment Deferred Tax Assets, Property, Plant and Equipment USD 635,000 2025-12-31 2025 FY 10-K 2026-03-12 0001055726-26-000008
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 2.50M 2025-12-31 2025 FY 10-K 2026-03-12 0001055726-26-000008
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Deferred Rent USD 0 2019-12-31 2019 FY 10-K 2020-03-12 0001055726-20-000012
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 378.48M 2025-12-31 2025 FY 10-K 2026-03-12 0001055726-26-000008
us-gaap DeferredTaxLiabilities Deferred Tax Liabilities, Net USD 0 2025-12-31 2025 FY 10-K 2026-03-12 0001055726-26-000008
us-gaap DeferredTaxLiabilitiesFinancingArrangements Deferred Tax Liabilities, Financing Arrangements USD 0 2020-12-31 2020 FY 10-K 2021-03-01 0001055726-21-000018
us-gaap DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets Deferred Tax Liabilities, Intangible Assets USD 0 2023-12-31 2023 FY 10-K 2024-03-06 0001055726-24-000011
us-gaap DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates Deferred Tax Liabilities, Investment in Noncontrolled Affiliates USD 0 2019-12-31 2019 FY 10-K 2020-03-12 0001055726-20-000012
us-gaap DeferredTaxLiabilitiesNoncurrent Deferred Tax Liabilities, Net, Noncurrent USD 174,793 2017-06-30 2017 Q2 10-Q 2017-08-08 0001055726-17-000036
us-gaap DeferredTaxLiabilitiesPropertyPlantAndEquipment Deferred Tax Liabilities, Property, Plant and Equipment USD 0 2022-12-31 2022 FY 10-K 2023-03-01 0001055726-23-000010
us-gaap DefinedContributionPlanCostRecognized Defined Contribution Plan, Cost USD 1.10M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001055726-26-000008
us-gaap DefinedContributionPlanEmployerMatchingContributionPercent Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay pure 0.06 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001055726-26-000008
us-gaap DefinedContributionPlanEmployerMatchingContributionPercentOfMatch Defined Contribution Plan, Employer Matching Contribution, Percent of Match pure 0.5 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001055726-26-000008
us-gaap DepositsAssetsCurrent Deposits Assets, Current USD 50.00M 2020-12-31 2021 FY 10-K 2022-03-01 0001055726-22-000008
us-gaap Depreciation Depreciation USD 960,912 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001055726-26-000029
us-gaap DerivativeLiabilities Derivative Liability USD 0 2020-09-30 2020 Q3 10-Q 2020-11-09 0001055726-20-000052
us-gaap DerivativeLiabilitiesCurrent Derivative Liability, Current USD 70.01M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001055726-26-000029
us-gaap DerivativeLiabilitiesNoncurrent Derivative Liability, Noncurrent USD 0 2020-12-31 2020 FY 10-K 2021-03-01 0001055726-21-000018
us-gaap DilutiveSecurities Dilutive Securities, Effect on Basic Earnings Per Share USD -116,477 2017-01-01 2017-03-31 2017 Q1 10-Q 2017-05-10 0001055726-17-000024
us-gaap DilutiveSecuritiesEffectOnBasicEarningsPerShareOther Dilutive Securities, Effect on Basic Earnings Per Share, Dilutive Convertible Securities USD 0 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-09 0001055726-20-000052
us-gaap DueFromRelatedPartiesCurrent Due from Related Parties, Current USD 134,320 2012-09-30 2012 Q3 10-Q 2012-11-07 0001193125-12-457586
us-gaap DueToRelatedPartiesCurrent Due to Related Parties, Current USD 1.42M 2023-03-31 2023 Q1 10-Q 2023-05-10 0001055726-23-000030
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -0.9 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001055726-26-000029
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -0.27 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-10 0001055726-21-000040
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -0.9 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001055726-26-000029
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001055726-26-000008
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001055726-26-000008
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.194 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001055726-26-000008
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure -0.006 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001055726-26-000008
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure -0.012 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001055726-26-000008
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure -0.001 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001055726-26-000008
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0.005 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001055726-26-000008
us-gaap EffectiveIncomeTaxRateReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Percent pure -0.018 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001055726-26-000008
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure -0.032 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001055726-26-000008
us-gaap EffectOfExchangeRateOnCashAndCashEquivalents Effect of Exchange Rate on Cash and Cash Equivalents USD 0 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-15 0001055726-17-000013
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001055726-26-000008
us-gaap EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet Embedded Derivative, Gain (Loss) on Embedded Derivative, Net USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-01 0001055726-23-000010
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount USD 2.30M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001055726-26-000029
us-gaap EquityMethodInvestmentOwnershipPercentage Equity Method Investment, Ownership Percentage pure 0.2 2015-06-30 2016 Q2 10-Q 2016-08-08 0001055726-16-000062
us-gaap EquityMethodInvestments Equity Method Investments USD 0 2021-12-31 2021 FY 10-K 2022-03-01 0001055726-22-000008
us-gaap EquitySecuritiesFvNi Equity Securities, FV-NI USD 2.10M 2025-12-31 2026 Q3 10-Q 2026-11-10 0001055726-26-000029
us-gaap EquitySecuritiesFvNiCurrentAndNoncurrent EquitySecuritiesFvNiCurrentAndNoncurrent USD 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001055726-26-000029
us-gaap EquitySecuritiesFvNiUnrealizedGain Equity Securities, FV-NI, Unrealized Gain USD 625,000 2020-01-01 2020-09-30 2021 Q3 10-Q 2021-11-09 0001055726-21-000062
us-gaap EquitySecuritiesFvNiUnrealizedGainLoss Equity Securities, FV-NI, Unrealized Gain (Loss) USD 302,606 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001055726-26-000029
us-gaap EquitySecuritiesFvNiUnrealizedLoss Equity Securities, FV-NI, Unrealized Loss USD 10.60M 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-08 0001055726-22-000055
us-gaap EstimatedInsuranceRecoveries Estimated Insurance Recoveries USD 0 2023-12-31 2023 FY 10-K 2024-03-06 0001055726-24-000011
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD 8.93M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001055726-26-000029
us-gaap FairValueAssumptionsExpectedDividendPayments Fair Value Assumptions, Expected Dividend Payments (Deprecated 2018-01-31) USD 0 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-09 0001055726-18-000026
us-gaap FairValueAssumptionsExpectedVolatilityRate Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31) pure 0.65 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-09 0001055726-18-000026
us-gaap FairValueAssumptionsRiskFreeInterestRate Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) pure 0.019 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-09 0001055726-18-000026
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1 Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings USD -2.10M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001055726-26-000029
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3 USD 2.10M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001055726-26-000029
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value USD 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001055726-26-000029
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings USD 8.90M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001055726-26-000029
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances USD 16.06M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-18 0001055726-25-000012
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements USD 84.49M 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-01 0001055726-21-000018
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value USD 11.42M 2025-06-30 2025 Q2 10-Q 2025-08-12 0001055726-25-000055
us-gaap FinancialLiabilitiesFairValueDisclosure Financial Liabilities Fair Value Disclosure USD 70.01M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001055726-26-000029
us-gaap FiniteLivedIntangibleAssetsAccumulatedAmortization Finite-Lived Intangible Assets, Accumulated Amortization USD 7.17M 2023-12-31 2023 FY 10-K 2024-03-06 0001055726-24-000011
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive Finite-Lived Intangible Asset, Expected Amortization, after Year Five USD 845,000 2022-12-31 2022 FY 10-K 2023-03-01 0001055726-23-000010
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths Finite-Lived Intangible Asset, Expected Amortization, Year One USD 253,000 2023-03-31 2023 Q1 10-Q 2023-05-10 0001055726-23-000030
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year USD 190,000 2023-03-31 2023 Q1 10-Q 2023-05-10 0001055726-23-000030
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFive Finite-Lived Intangible Asset, Expected Amortization, Year Five USD 253,000 2022-12-31 2022 FY 10-K 2023-03-01 0001055726-23-000010
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFour Finite-Lived Intangible Asset, Expected Amortization, Year Four USD 253,000 2023-03-31 2023 Q1 10-Q 2023-05-10 0001055726-23-000030
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearThree Finite-Lived Intangible Asset, Expected Amortization, Year Three USD 253,000 2023-03-31 2023 Q1 10-Q 2023-05-10 0001055726-23-000030
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo Finite-Lived Intangible Asset, Expected Amortization, Year Two USD 253,000 2023-03-31 2023 Q1 10-Q 2023-05-10 0001055726-23-000030
us-gaap FiniteLivedIntangibleAssetsGross Finite-Lived Intangible Assets, Gross USD 9.15M 2023-12-31 2023 FY 10-K 2024-03-06 0001055726-24-000011
us-gaap FiniteLivedIntangibleAssetsNet Finite-Lived Intangible Assets, Net USD 0 2023-12-31 2023 FY 10-K 2024-03-06 0001055726-24-000011
us-gaap ForeignCurrencyTransactionGainLossBeforeTax Foreign Currency Transaction Gain (Loss), before Tax USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-06 0001055726-24-000011
us-gaap GainLossOnDispositionOfAssets Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property USD 0 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-08 0001055726-17-000039
us-gaap GainLossOnDispositionOfIntangibleAssets Gain (Loss) on Disposition of Intangible Assets USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-06 0001055726-24-000011
us-gaap GainLossOnInvestments Gain (Loss) on Investments USD 153,252 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-09 0001055726-21-000055
us-gaap GainLossOnSaleOfInvestments Gain (Loss) on Sale of Investments USD 1.14M 2009-01-01 2009-12-31 2011 FY 10-K 2012-03-15 0001193125-12-117292
us-gaap GainLossOnSaleOfOtherInvestments Gain (Loss) on Sale of Other Investments USD -1.03M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001055726-26-000029
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001055726-26-000008
us-gaap GainsLossesOnSalesOfAssets Gain (Loss) on Disposition of Assets for Financial Service Operations USD 501,000 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-16 0001055726-15-000003
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 24.88M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001055726-26-000029
us-gaap Goodwill Goodwill USD 0 2023-12-31 2023 FY 10-K 2024-03-06 0001055726-24-000011
us-gaap GoodwillAndIntangibleAssetImpairment Goodwill and Intangible Asset Impairment USD 12.50M 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-06 0001055726-24-000011
us-gaap GoodwillGross Goodwill, Gross USD 10.51M 2023-12-31 2023 FY 10-K 2024-03-06 0001055726-24-000011
us-gaap GoodwillImpairmentLoss Goodwill, Impairment Loss USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-18 0001055726-25-000012
us-gaap ImpairmentOfIntangibleAssetsExcludingGoodwill Impairment of Intangible Assets (Excluding Goodwill) USD 0 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-06 0001055726-24-000011
us-gaap ImpairmentOfIntangibleAssetsFinitelived Impairment of Intangible Assets, Finite-lived USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-18 0001055726-25-000012
us-gaap ImpairmentOfLongLivedAssetsHeldForUse Impairment of Long-Lived Assets Held-for-use USD 0 2012-01-01 2012-12-31 2012 FY 10-K 2013-03-18 0001445305-13-000665
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD -84.95M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001055726-26-000008
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -84.95M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001055726-26-000008
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-18 0001055726-25-000012
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest USD -135.12M 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-06 0001055726-24-000011
us-gaap IncomeLossFromEquityMethodInvestments Income (Loss) from Equity Method Investments USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-06 0001055726-24-000011
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001055726-26-000008
us-gaap IncomeTaxExpenseBenefitContinuingOperations Income Tax Expense (Benefit), Continuing Operations (Deprecated 2013-01-31) USD 30,000 2012-01-01 2012-12-31 2012 FY 10-K 2013-03-18 0001445305-13-000665
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 16.48M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001055726-26-000008
us-gaap IncomeTaxReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount USD 403,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-18 0001055726-25-000012
us-gaap IncomeTaxReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-18 0001055726-25-000012
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -17.84M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001055726-26-000008
us-gaap IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses Effective Income Tax Rate Reconciliation, Nondeductible Expense, Impairment Losses, Amount USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-18 0001055726-25-000012
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD 536,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001055726-26-000008
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 1.05M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001055726-26-000008
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD 118,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001055726-26-000008
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD -410,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001055726-26-000008
us-gaap IncomeTaxReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Amount USD 1.50M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001055726-26-000008
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD 2.74M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001055726-26-000008
us-gaap IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities USD 2.25M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001055726-26-000029
us-gaap IncreaseDecreaseInAccountsPayableRelatedParties Increase (Decrease) in Accounts Payable, Related Parties USD 859,354 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-10 0001055726-22-000034
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD -220,466 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-10 0001055726-25-000063
us-gaap IncreaseDecreaseInAccountsReceivableRelatedParties Increase (Decrease) in Accounts Receivable, Related Parties USD 2.06M 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-01 0001055726-22-000008
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD -1.17M 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-12 0001055726-19-000058
us-gaap IncreaseDecreaseInContractWithCustomerLiability Increase (Decrease) in Contract with Customer, Liability USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-06 0001055726-24-000011
us-gaap IncreaseDecreaseInDeferredIncomeTaxes Increase (Decrease) in Deferred Income Taxes USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-01 0001055726-22-000008
us-gaap IncreaseDecreaseInDeferredRentReceivables Increase (Decrease) in Deferred Rent Receivables (Deprecated 2012-01-31) USD 215 2012-01-01 2012-03-31 2012 Q1 10-Q 2012-05-09 0001193125-12-222402
us-gaap IncreaseDecreaseInDeferredRevenue Increase (Decrease) in Deferred Revenue USD 651,505 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001055726-26-000029
us-gaap IncreaseDecreaseInDerivativeLiabilities Increase (Decrease) in Derivative Liabilities USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-01 0001055726-23-000010
us-gaap IncreaseDecreaseInOtherAccruedLiabilities Increase (Decrease) in Other Accrued Liabilities USD 0 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-09 0001055726-21-000055
us-gaap IncreaseDecreaseInOtherCurrentLiabilities Increase (Decrease) in Other Current Liabilities USD 261,325 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-09 0001055726-18-000026
us-gaap IncreaseDecreaseInOtherOperatingAssets Increase (Decrease) in Other Operating Assets USD -95,406 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001055726-26-000029
us-gaap IncreaseDecreaseInOtherOperatingLiabilities Increase (Decrease) in Other Operating Liabilities USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-06 0001055726-24-000011
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 469,496 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001055726-26-000029
us-gaap IncreaseDecreaseInRestrictedCash Increase (Decrease) in Restricted Cash USD 0 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-15 0001055726-17-000013
us-gaap IncrementalCommonSharesAttributableToCallOptionsAndWarrants Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants shares 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-12 0001055726-20-000012
us-gaap IntangibleAssetsNetExcludingGoodwill Intangible Assets, Net (Excluding Goodwill) USD 0 2023-12-31 2023 FY 10-K 2024-03-06 0001055726-24-000011
us-gaap InterestAndOtherIncome Interest and Other Income USD 920,891 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-12 0001055726-19-000012
us-gaap InterestExpense Interest Expense USD 177,833 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-13 0001055726-24-000020
us-gaap InterestExpenseNonoperating InterestExpenseNonoperating USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001055726-26-000008
us-gaap InterestExpenseOperating InterestExpenseOperating USD 177,833 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-08 0001055726-24-000046
us-gaap InterestIncomeExpenseNet Interest Income (Expense), Net USD -169,300 2018-10-01 2018-12-31 2019 FY 10-K 2020-03-12 0001055726-20-000012
us-gaap InterestIncomeOperating Interest Income, Operating USD 2.81M 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-08 0001055726-24-000046
us-gaap InterestPaid Interest Paid, Including Capitalized Interest, Operating and Investing Activities USD 0 2012-01-01 2012-12-31 2012 FY 10-K 2013-03-18 0001445305-13-000665
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001055726-26-000008
us-gaap InvestmentIncomeAmortizationOfPremium Investment Income, Amortization of Premium USD 125,810 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-10 0001055726-22-000034
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 1.16M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001055726-26-000029
us-gaap InvestmentIncomeNetAmortizationOfDiscountAndPremium Investment Income, Net, Amortization of Discount and Premium USD 18,094 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001055726-26-000029
us-gaap InvestmentOwnedAtFairValue Investment Owned, at Fair Value USD 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001055726-26-000029
us-gaap InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures USD 6.32M 2019-06-30 2019 Q2 10-Q 2019-08-08 0001055726-19-000052
us-gaap LeaseCost Lease, Cost USD 1.90M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001055726-26-000029
us-gaap LeaseholdImprovementsGross Leasehold Improvements, Gross USD 1.80M 2013-09-30 2013 Q3 10-Q 2013-11-12 0001055726-13-000011
us-gaap LeaseIncentiveReceivable Lease Incentive Receivable USD 0 2018-12-31 2018 FY 10-K 2019-03-12 0001055726-19-000012
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 8.35M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001055726-26-000029
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 2.13M 2023-12-31 2023 FY 10-K 2024-03-06 0001055726-24-000011
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths Lessee, Operating Lease, Liability, Payments, Due Next Rolling Twelve Months USD 3.25M 2023-12-31 2023 FY 10-K 2024-03-06 0001055726-24-000011
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 2.99M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001055726-26-000029
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 2.13M 2024-12-31 2024 FY 10-K 2025-03-18 0001055726-25-000012
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 2.13M 2025-12-31 2025 FY 10-K 2026-03-12 0001055726-26-000008
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 2.13M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001055726-26-000029
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 2.32M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001055726-26-000029
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 905,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001055726-26-000029
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 1.07M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001055726-26-000029
us-gaap Liabilities Liabilities USD 94.06M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001055726-26-000029
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 60.14M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001055726-26-000029
us-gaap LiabilitiesCurrent Liabilities, Current USD 89.47M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001055726-26-000029
us-gaap LiabilitiesFairValueDisclosure Financial and Nonfinancial Liabilities, Fair Value Disclosure USD 6.16M 2012-09-30 2012 Q3 10-Q 2012-11-07 0001193125-12-457586
us-gaap LicensesRevenue Licenses Revenue (Deprecated 2018-01-31) USD 1.29M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-09 0001055726-18-000026
us-gaap LineOfCreditFacilityIncreaseAccruedInterest Line of Credit Facility, Increase, Accrued Interest USD 0 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-15 0001055726-17-000013
us-gaap LitigationReserveCurrent Estimated Litigation Liability, Current USD 0 2023-03-31 2023 Q1 10-Q 2023-05-10 0001055726-23-000030
us-gaap LongTermDebt Long-term Debt USD 62.76M 2019-06-30 2019 Q2 10-Q 2019-08-08 0001055726-19-000052
us-gaap LongTermDebtFairValue Long-term Debt, Fair Value USD 62.20M 2019-12-31 2019 FY 10-K 2020-03-12 0001055726-20-000012
us-gaap LongTermInvestments Long-term Investments USD 21.20M 2020-03-31 2020 Q1 10-Q 2020-05-11 0001055726-20-000032
us-gaap LossContingencyAccrualAtCarryingValue Loss Contingency Accrual USD 80,000 2015-09-30 2015 Q3 10-Q 2015-11-09 0001055726-15-000015
us-gaap MarketableSecurities Marketable Securities USD 83.18M 2018-06-30 2018 Q2 10-Q 2018-08-07 0001055726-18-000040
us-gaap MinorityInterest Stockholders' Equity Attributable to Noncontrolling Interest USD 0 2020-12-31 2020 FY 10-K 2021-03-01 0001055726-21-000018
us-gaap MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders USD 149,559 2016-01-01 2016-12-31 2018 FY 10-K 2019-03-12 0001055726-19-000012
us-gaap MinorityInterestDecreaseFromRedemptions Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests USD 0 2020-01-01 2020-12-31 2022 FY 10-K 2023-03-01 0001055726-23-000010
us-gaap MinorityInterestOwnershipPercentageByNoncontrollingOwners Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners pure 0.15 2018-06-30 2018 Q2 10-Q 2018-08-07 0001055726-18-000040
us-gaap MinorityInterestOwnershipPercentageByParent Noncontrolling Interest, Ownership Percentage by Parent pure 0.85 2014-05-31 2017 FY 10-K 2018-03-14 0001055726-18-000014
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 45.10M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001055726-26-000029
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD 12.51M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001055726-26-000029
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -54.91M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001055726-26-000029
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -74.90M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001055726-26-000029
us-gaap NetIncomeLossAttributableToNoncontrollingInterest Net Income (Loss) Attributable to Noncontrolling Interest USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-01 0001055726-23-000010
us-gaap NetIncomeLossAttributableToParentDiluted Net Income (Loss) Attributable to Parent, Diluted USD -196.71M 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-09 0001055726-21-000062
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -119.36M 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-12 0001055726-20-000012
us-gaap NetIncomeLossAvailableToCommonStockholdersDiluted Net Income (Loss) Available to Common Stockholders, Diluted USD -142.07M 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-09 0001055726-20-000052
us-gaap NoncontrollingInterestDecreaseFromDeconsolidation Noncontrolling Interest, Decrease from Deconsolidation USD 3.18M 2020-01-01 2020-12-31 2022 FY 10-K 2023-03-01 0001055726-23-000010
us-gaap NoncontrollingInterestIncreaseFromBusinessCombination Noncontrolling Interest, Increase from Business Combination USD 670,307 2009-01-01 2009-12-31 2011 FY 10-K 2012-03-15 0001193125-12-117292
us-gaap NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance Noncontrolling Interest, Increase from Subsidiary Equity Issuance USD 2.38M 2020-01-01 2020-12-31 2022 FY 10-K 2023-03-01 0001055726-23-000010
us-gaap NumberOfOperatingSegments Number of Operating Segments segment 1 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-06 0001055726-24-000011
us-gaap NumberOfReportableSegments Number of Reportable Segments segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001055726-26-000029
us-gaap OperatingExpenses Operating Expenses USD 60.40M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001055726-26-000029
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -60.10M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001055726-26-000029
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 7.28M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001055726-26-000029
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 2.69M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001055726-26-000029
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 4.59M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001055726-26-000029
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 5.21M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001055726-26-000029
us-gaap OperatingLeaseRightOfUseAssetAmortizationExpense Operating Lease, Right-of-Use Asset, Amortization Expense USD 1.33M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001055726-26-000029
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 35.65M 2019-12-31 2019 FY 10-K 2020-03-12 0001055726-20-000012
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 3.76M 2019-12-31 2019 FY 10-K 2020-03-12 0001055726-20-000012
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFiveYears Operating Leases, Future Minimum Payments, Due in Five Years USD 4.02M 2019-12-31 2019 FY 10-K 2020-03-12 0001055726-20-000012
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 4.05M 2019-12-31 2019 FY 10-K 2020-03-12 0001055726-20-000012
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 3.98M 2019-12-31 2019 FY 10-K 2020-03-12 0001055726-20-000012
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 3.89M 2019-12-31 2019 FY 10-K 2020-03-12 0001055726-20-000012
us-gaap OperatingLeasesFutureMinimumPaymentsDueThereafter Operating Leases, Future Minimum Payments, Due Thereafter USD 15.95M 2019-12-31 2019 FY 10-K 2020-03-12 0001055726-20-000012
us-gaap OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear Operating Leases, Future Minimum Payments, Remainder of Fiscal Year USD 831,000 2018-09-30 2018 Q3 10-Q 2018-11-08 0001055726-18-000045
us-gaap OperatingLeasesRentExpenseNet Operating Leases, Rent Expense, Net USD 3.20M 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-12 0001055726-19-000012
us-gaap OperatingLeasesRentExpenseSubleaseRentals1 Operating Leases, Rent Expense, Sublease Rentals USD 0 2012-01-01 2012-12-31 2012 FY 10-K 2013-03-18 0001445305-13-000665
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.09 2026-09-30 2026 Q3 10-Q 2026-11-10 0001055726-26-000029
us-gaap OtherAccruedLiabilitiesCurrentAndNoncurrent Other Accrued Liabilities USD 5.95M 2023-03-31 2023 Q1 10-Q 2023-05-10 0001055726-23-000030
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 1.92M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001055726-26-000029
us-gaap OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax (Deprecated 2012-01-31) USD 495 2012-01-01 2012-03-31 2012 Q1 10-Q 2012-05-09 0001193125-12-222402
us-gaap OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, Tax USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-01 0001055726-22-000008
us-gaap OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001055726-26-000008
us-gaap OtherComprehensiveIncomeLossTax Other Comprehensive Income (Loss), Tax USD 335,000 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-12 0001055726-19-000058
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax USD 370,893 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001055726-26-000029
us-gaap OtherEmployeeRelatedLiabilitiesCurrent Other Employee-related Liabilities, Current USD 0 2012-12-31 2012 FY 10-K 2013-03-18 0001445305-13-000665
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 261,325 2018-03-31 2018 Q1 10-Q 2018-05-09 0001055726-18-000026
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 0 2022-12-31 2022 FY 10-K 2023-03-01 0001055726-23-000010
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD -5.23M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001055726-26-000029
us-gaap OtherPrepaidExpenseCurrent Other Prepaid Expense, Current USD 2.82M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001055726-26-000029
us-gaap OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale Other-than-temporary Impairment Loss, Debt Securities, Available-for-sale USD 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-12 0001055726-19-000012
us-gaap OtherThanTemporaryImpairmentLossDebtSecuritiesPortionRecognizedInEarnings Other-than-temporary Impairment Loss, Debt Securities, Portion Recognized in Earnings USD 36,000 2019-01-01 2019-03-31 2019 Q1 10-Q 2019-05-09 0001055726-19-000029
us-gaap OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities Other than Temporary Impairment Losses, Investments, Available-for-sale Securities USD 0 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-14 0001055726-18-000014
us-gaap OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet Other than Temporary Impairment Losses, Investments, Portion Recognized in Earnings, Net USD 253,000 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-09 0001055726-18-000026
us-gaap PaymentsForDeposits Payments for Deposits USD 30.00M 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-01 0001055726-22-000008
us-gaap PaymentsForProceedsFromInvestments Payments for (Proceeds from) Investments USD -40.13M 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-09 0001055726-20-000052
us-gaap PaymentsOfCapitalDistribution Payments of Capital Distribution USD 1.00M 2016-01-01 2016-12-31 2017 FY 10-K 2018-03-14 0001055726-18-000014
us-gaap PaymentsOfDebtIssuanceCosts Payments of Debt Issuance Costs USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-01 0001055726-22-000008
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 531,000 2021-01-01 2021-03-31 2022 Q1 10-Q 2022-05-10 0001055726-22-000034
us-gaap PaymentsRelatedToTaxWithholdingForShareBasedCompensation Payment, Tax Withholding, Share-based Payment Arrangement USD 466,646 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-09 0001055726-23-000055
us-gaap PaymentsToAcquireAdditionalInterestInSubsidiaries Payments to Acquire Additional Interest in Subsidiaries USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-06 0001055726-24-000011
us-gaap PaymentsToAcquireIntangibleAssets Payments to Acquire Intangible Assets USD 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-12 0001055726-19-000012
us-gaap PaymentsToAcquireInterestInSubsidiariesAndAffiliates Payments to Acquire Interest in Subsidiaries and Affiliates USD 0 2013-01-01 2013-12-31 2013 FY 10-K 2014-03-17 0001055726-14-000003
us-gaap PaymentsToAcquireOtherInvestments Payments to Acquire Other Investments USD 101,123 2011-01-01 2011-09-30 2012 Q3 10-Q 2012-11-07 0001193125-12-457586
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001055726-26-000029
us-gaap PaymentsToAcquireShortTermInvestments Payments to Acquire Short-term Investments USD 1.98M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001055726-26-000029
us-gaap PaymentsToMinorityShareholders Payments to Noncontrolling Interests USD 0 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-08 0001055726-17-000039
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0.001 2025-12-31 2025 FY 10-K 2026-03-12 0001055726-26-000008
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 10.00M 2025-12-31 2025 FY 10-K 2026-03-12 0001055726-26-000008
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 9 2025-12-31 2025 FY 10-K 2026-03-12 0001055726-26-000008
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 9 2025-12-31 2025 FY 10-K 2026-03-12 0001055726-26-000008
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001055726-26-000029
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 3.08M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001055726-26-000029
us-gaap PrepaidExpenseCurrentAndNoncurrent Prepaid Expense USD 273,000 2022-09-30 2022 Q3 10-Q 2022-11-08 0001055726-22-000055
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 81.90M 2015-05-01 2015-05-31 2016 FY 10-K 2017-03-15 0001055726-17-000013
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 7.35M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001055726-26-000029
us-gaap ProceedsFromIssuanceOfLongTermDebt Proceeds from Issuance of Long-term Debt USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-01 0001055726-22-000008
us-gaap ProceedsFromIssuanceOfWarrants Proceeds from Issuance of Warrants USD 33.95M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001055726-26-000029
us-gaap ProceedsFromIssuanceOrSaleOfEquity Proceeds from Issuance or Sale of Equity USD 21.00M 2026-07-31 2026 Q3 10-Q 2026-11-10 0001055726-26-000029
us-gaap ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments Proceeds from Maturities, Prepayments and Calls of Short-term Investments USD 2.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001055726-26-000029
us-gaap ProceedsFromMinorityShareholders Proceeds from Noncontrolling Interests USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-01 0001055726-23-000010
us-gaap ProceedsFromNotesPayable Proceeds from Notes Payable USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-01 0001055726-23-000010
us-gaap ProceedsFromPaymentsForOtherFinancingActivities Proceeds from (Payments for) Other Financing Activities USD 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-12 0001055726-19-000012
us-gaap ProceedsFromSaleAndMaturityOfMarketableSecurities Proceeds from Sale and Maturity of Marketable Securities USD 0 2012-01-01 2012-12-31 2012 FY 10-K 2013-03-18 0001445305-13-000665
us-gaap ProceedsFromSaleOfEquityMethodInvestments Proceeds from Sale of Equity Method Investments USD 0 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-09 0001055726-21-000062
us-gaap ProceedsFromSaleOfEquitySecuritiesFvNi ProceedsFromSaleOfEquitySecuritiesFvNi USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-01 0001055726-23-000010
us-gaap ProceedsFromSaleOfIntangibleAssets Proceeds from Sale of Intangible Assets USD 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-12 0001055726-20-000012
us-gaap ProceedsFromSaleOfProductiveAssets Proceeds from Sale of Productive Assets USD 650,000 2012-01-01 2012-09-30 2012 Q3 10-Q 2012-11-07 0001193125-12-457586
us-gaap ProceedsFromSaleOfPropertyPlantAndEquipment Proceeds from Sale of Property, Plant, and Equipment USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001055726-26-000008
us-gaap ProceedsFromSaleOfShortTermInvestments Proceeds from Sale of Short-term Investments USD 12.49M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001055726-26-000029
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 823 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001055726-26-000008
us-gaap ProceedsFromWarrantExercises Proceeds from Warrant Exercises USD 3.99M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001055726-26-000029
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -279.82M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-01 0001055726-23-000010
us-gaap PropertyPlantAndEquipmentDisposals Property, Plant and Equipment, Disposals USD 37,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-12 0001055726-26-000008
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 19.95M 2025-12-31 2025 FY 10-K 2026-03-12 0001055726-26-000008
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 1.57M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001055726-26-000029
us-gaap PurchaseObligation Purchase Obligation USD 47.40M 2021-12-31 2021 FY 10-K 2022-03-01 0001055726-22-000008
us-gaap RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty Related Party Transaction, Other Revenues from Transactions with Related Party USD 2.57M 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-14 0001055726-18-000014
us-gaap RepaymentsOfConvertibleDebt Repayments of Convertible Debt USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001055726-26-000008
us-gaap RepaymentsOfLinesOfCredit Repayments of Lines of Credit USD 0 2012-01-01 2012-12-31 2012 FY 10-K 2013-03-18 0001445305-13-000665
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 35.51M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001055726-26-000029
us-gaap RestrictedCashAndCashEquivalents Restricted Cash and Cash Equivalents USD 0 2014-12-31 2014 FY 10-K 2015-03-16 0001055726-15-000003
us-gaap RestructuringCharges Restructuring Charges USD 2.20M 2019-07-01 2019-09-30 2019 FY 10-K 2020-03-12 0001055726-20-000012
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -1.89B 2026-09-30 2026 Q3 10-Q 2026-11-10 0001055726-26-000029
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 298,901 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001055726-26-000029
us-gaap RevenueFromGrants Revenue from Grants (Deprecated 2018-01-31) USD 92,590 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-09 0001055726-18-000026
us-gaap Revenues Revenues USD 1.53M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-09 0001055726-18-000026
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-01 0001055726-22-000008
us-gaap SaleOfStockConsiderationReceivedOnTransaction Sale of Stock, Consideration Received on Transaction USD 27.60M 2024-12-16 2026 Q3 10-Q 2026-11-10 0001055726-26-000029
us-gaap SaleOfStockNumberOfSharesIssuedInTransaction Sale of Stock, Number of Shares Issued in Transaction shares 12.50M 2026-04-06 2026 Q3 10-Q 2026-11-10 0001055726-26-000029
us-gaap SaleOfStockPricePerShare Sale of Stock, Price Per Share USD/shares 0.95 2026-07-31 2026 Q3 10-Q 2026-11-10 0001055726-26-000029
us-gaap SalesRevenueNet Revenue, Net (Deprecated 2018-01-31) USD 42.22M 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-14 0001055726-18-000014
us-gaap SecurityDeposit Security Deposit USD 64,000 2013-04-30 2013 Q3 10-Q 2013-11-12 0001055726-13-000011
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 2.34M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001055726-26-000029
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 1.31 2012-01-01 2012-09-30 2012 Q3 10-Q 2012-11-07 0001193125-12-457586
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum pure 0.019 2011-01-01 2011-09-30 2012 Q3 10-Q 2012-11-07 0001193125-12-457586
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum pure 0.004 2012-01-01 2012-09-30 2012 Q3 10-Q 2012-11-07 0001193125-12-457586
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised shares 284,091 2018-07-01 2018-09-30 2018 FY 10-K 2019-03-12 0001055726-19-000012
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant shares 1.92M 2012-06-30 2012 Q2 10-Q 2012-08-09 0001193125-12-347489
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 0 2025-12-31 2025 FY 10-K 2026-03-12 0001055726-26-000008
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 100 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001055726-26-000008
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period shares 40,736 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001055726-26-000008
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period shares 77,563 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001055726-26-000008
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price USD/shares 67.03 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001055726-26-000008
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 763,990 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001055726-26-000008
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 1.27 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001055726-26-000029
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 2.02M 2025-12-31 2025 FY 10-K 2026-03-12 0001055726-26-000008
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 28.05 2025-12-31 2025 FY 10-K 2026-03-12 0001055726-26-000008
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 1.98 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001055726-26-000008
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price USD/shares 91.31 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001055726-26-000008
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 2.02 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001055726-26-000008
us-gaap SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price USD/shares 42.81 2025-12-31 2025 FY 10-K 2026-03-12 0001055726-26-000008
us-gaap ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable shares 1.25M 2025-12-31 2025 FY 10-K 2026-03-12 0001055726-26-000008
us-gaap ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions Share-based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding shares 2.02M 2025-12-31 2025 FY 10-K 2026-03-12 0001055726-26-000008
us-gaap SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price USD/shares 28.05 2025-12-31 2025 FY 10-K 2026-03-12 0001055726-26-000008
us-gaap SharesIssuedPricePerShare Shares Issued, Price Per Share USD/shares 8.41 2017-06-30 2017 Q2 10-Q 2017-08-08 0001055726-17-000036
us-gaap ShortTermInvestments Short-term Investments USD 1.40M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001055726-26-000029
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD -33.92M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001055726-26-000029
us-gaap StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD 222.36M 2022-12-31 2022 FY 10-K 2023-03-01 0001055726-23-000010
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 0.083 2024-01-24 2024 FY 10-K 2025-03-18 0001055726-25-000012
us-gaap StockIssued1 Stock Issued USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-18 0001055726-25-000012
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 20.36M 2021-01-25 2021 Q3 10-Q 2021-11-09 0001055726-21-000062
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 416 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001055726-26-000008
us-gaap StockIssuedDuringPeriodValueAcquisitions Stock Issued During Period, Value, Acquisitions USD 4.30M 2016-01-01 2016-12-31 2018 FY 10-K 2019-03-12 0001055726-19-000012
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 4.38M 2021-01-01 2021-12-31 2023 FY 10-K 2024-03-06 0001055726-24-000011
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments Stock Issued During Period, Value, Conversion of Convertible Securities, Net of Adjustments USD 4.83M 2009-01-01 2009-12-31 2011 FY 10-K 2012-03-15 0001193125-12-117292
us-gaap StockIssuedDuringPeriodValueIssuedForServices Stock Issued During Period, Value, Issued for Services USD 14.00M 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-18 0001055726-25-000012
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 3.01M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001055726-26-000029
us-gaap StockIssuedDuringPeriodValueShareBasedCompensation Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture USD -811 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001055726-26-000029
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 168,665 2010-01-01 2010-12-31 2011 FY 10-K 2012-03-15 0001193125-12-117292
us-gaap StraightLineRent Straight Line Rent USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-01 0001055726-21-000018
us-gaap TenantImprovements Tenant Improvements USD 933,000 2017-06-30 2017 Q2 10-Q 2017-08-08 0001055726-17-000036
us-gaap UnrealizedGainLossOnInvestments Unrealized Gain (Loss) on Investments USD -28,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001055726-26-000029
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 26.02M 2025-12-31 2025 FY 10-K 2026-03-12 0001055726-26-000008
us-gaap UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions USD 201,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001055726-26-000008
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions USD 1.61M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001055726-26-000008
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions USD 197,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-12 0001055726-26-000008
us-gaap UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate Unrecognized Tax Benefits that Would Impact Effective Tax Rate USD 24.40M 2025-12-31 2025 FY 10-K 2026-03-12 0001055726-26-000008
us-gaap WarrantsAndRightsOutstanding Warrants and Rights Outstanding USD 70.01M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001055726-26-000029
us-gaap WeightedAverageNumberDilutedSharesOutstandingAdjustment Weighted Average Number Diluted Shares Outstanding Adjustment shares 0 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-09 0001055726-21-000062
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 83.23M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001055726-26-000029
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 202.41M 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-10 0001055726-21-000040
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 83.23M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001055726-26-000029

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →